“Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma”. (2021) Acta Biomedica Atenei Parmensis, 92(1), p. e2021037. doi:10.23750/abm.v92i1.9096.